Cilengitide: all 27 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00842712Phase 2Results posted
• Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter StatusCompletedNCT00813943Phase 2Results posted
• Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter StatusCompletedNCT00689221Phase 3Results posted
• Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyCompletedNCT00679354Phase 2Results posted
• Cilengitide in Treating Patients With Prostate CancerCompletedNCT00121238Phase 2Results posted
• Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma MultiformeTerminatedNCT00112866Phase 2Results posted
• Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)CompletedNCT00093964Phase 2Results posted
• Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00085254Phase 1/2Results posted
• Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)WithdrawnNCT01782976Phase 2
• Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and AdolescentsTerminatedNCT01517776Phase 2
• Pharmacokinetics in Subjects With Renal ImpairmentCompletedNCT01504165Phase 1
• Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by SurgeryCompletedNCT01276496Phase 1
• Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine GliomaCompletedNCT01165333Phase 1
• Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter GeneStatus unknownNCT01124240Phase 2
• Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma MultiformeTerminatedNCT01122888Phase 1
• Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung CancerCompletedNCT01118676Phase 1
• Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaCompletedNCT00979862Phase 1
• Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung CancerCompletedNCT00884598Phase 1
• Cilengitide in Treating Patients With Metastatic Prostate CancerCompletedNCT00103337Phase 2
• Cilengitide in Treating Patients With Acute Myeloid LeukemiaTerminatedNCT00089388Phase 2
• Cilengitide in Treating Patients With Unresectable or Metastatic MelanomaTerminatedNCT00082875Phase 2
• Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00077155Phase 1
• Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNCT00063973Phase 1
• EMD 121974 in Treating Patients With Advanced Solid TumorsCompletedNCT00022113Phase 1
• EMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaTerminatedNCT00006222Phase 1
• EMD 121974 in Treating Patients With Progressive or Recurrent GliomaCompletedNCT00006093Phase 1/2
• EMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00004258Phase 1

← Cilengitide overview